|
Re: Does anyone know the death rate for Omicron?
Posted 1/7/2022 11:16:12 AM by windyweather21 Pharmaceutical giant Moderna is pushing for the fourth round of COVID-19 boosters. In an interview Thursday, Moderna CEO Stephane Ancel said the efficiency of booster-shots will “likely” decline over time. He added, emerging new variants of COVID-19 will require a fourth dose of the vaccine “for some people.” Moderna’s stock rose from $115 per share to $215 over the past year as it shipped 800 million doses of its vaccine paid for by national governments. However, easing COVID-19 fears last October led to its stock decline by 34 percent. Most economists agree the financial performance of Big Pharma companies depends on how long COVID-19 will last and their stock could tumble once the crisis is over. |